147 related articles for article (PubMed ID: 9155083)
1. RBE variation as a function of depth in the 200-MeV proton beam produced at the National Accelerator Centre in Faure (South Africa).
Gueulette J; Böhm L; De Coster BM; Vynckier S; Octave-Prignot M; Schreuder AN; Symons JE; Jones DT; Wambersie A; Scalliet P
Radiother Oncol; 1997 Mar; 42(3):303-9. PubMed ID: 9155083
[TBL] [Abstract][Full Text] [Related]
2. Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy.
Gueulette J; Octave-Prignot M; De Costera BM; Wambersie A; Grégoire V
Radiother Oncol; 2004 Dec; 73 Suppl 2():S148-54. PubMed ID: 15971332
[TBL] [Abstract][Full Text] [Related]
3. Measurements of radiobiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvain-la-Neuve, Belgium.
Gueulette J; Grégoire V; Octave-Prignot M; Wambersie A
Radiat Res; 1996 Jan; 145(1):70-4. PubMed ID: 8532839
[TBL] [Abstract][Full Text] [Related]
4. Radiobiological intercomparison of the 160 MeV and 230 MeV proton therapy beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital.
Wouters BG; Skarsgard LD; Gerweck LE; Carabe-Fernandez A; Wong M; Durand RE; Nielson D; Bussiere MR; Wagner M; Biggs P; Paganetti H; Suit HD
Radiat Res; 2015 Feb; 183(2):174-87. PubMed ID: 25587741
[TBL] [Abstract][Full Text] [Related]
5. Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses.
Gueulette J; Bohm L; Slabbert JP; De Coster BM; Rutherfoord GS; Ruifrok A; Octave-Prignot M; Binns PJ; Schreuder AN; Symons JE; Scalliet P; Jones DT
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1051-8. PubMed ID: 10863078
[TBL] [Abstract][Full Text] [Related]
6. Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. Influence of motion.
Gueulette J; Blattmann H; Pedroni E; Coray A; De Coster BM; Mahy P; Wambersie A; Goitein G
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):838-45. PubMed ID: 15936568
[TBL] [Abstract][Full Text] [Related]
7. Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles.
Paganetti H
Phys Med Biol; 2002 Mar; 47(5):747-64. PubMed ID: 11931469
[TBL] [Abstract][Full Text] [Related]
8. Proton RBE for early intestinal tolerance in mice after fractionated irradiation.
Gueulette J; Slabbert JP; Böhm L; De Coster BM; Rosier JF; Octave-Prignot M; Ruifrok A; Schreuder AN; Wambersie A; Scalliet P; Jones DT
Radiother Oncol; 2001 Nov; 61(2):177-84. PubMed ID: 11690684
[TBL] [Abstract][Full Text] [Related]
9. Calculation of relative biological effectiveness for proton beams using biological weighting functions.
Paganetti H; Olko P; Kobus H; Becker R; Schmitz T; Waligorski MP; Filges D; Müller-Gärtner HW
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):719-29. PubMed ID: 9112472
[TBL] [Abstract][Full Text] [Related]
10. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay.
Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological intercomparison of two clinical neutron beams using the regeneration of mouse intestinal crypts.
Böhm L; Gueulette J; Jones DT; Beauduin M; Vynckier S; de Roubaix S; Yudelev M; Slabbert JP; Wambersie A
Strahlenther Onkol; 1990 Mar; 166(3):242-5. PubMed ID: 2109358
[TBL] [Abstract][Full Text] [Related]
12. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
[TBL] [Abstract][Full Text] [Related]
13. In vivo radiobiological characterization of proton beam at the National Cancer Center in Korea: effect of the Chk2 mutation.
Kim SS; Choo DW; Shin D; Baek HJ; Kim TH; Motoyama N; De Coster BM; Gueulette J; Furusawa Y; Ando K; Cho KH
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):559-62. PubMed ID: 21195877
[TBL] [Abstract][Full Text] [Related]
14. RBE variation between fast neutron beams as a function of energy. Intercomparison involving 7 neutrontherapy facilities.
Gueulette J; Beauduin M; Grégoire V; Vynckier S; De Coster BM; Octave-Prignot M; Wambersie A; Strijkmans K; De Schrijver A; El-Akkad S; Böhm L; Slabbert JP; Jones DT; Maughan R; Onoda J; Yudelev M; Porter AT; Powers WE; Sabattier R; Breteau N; Courdi A; Brassart N; Chauvel P
Bull Cancer Radiother; 1996; 83 Suppl():55s-63s. PubMed ID: 8949753
[TBL] [Abstract][Full Text] [Related]
15. Relative biological effectiveness of proton beams in clinical therapy.
Gerweck LE; Kozin SV
Radiother Oncol; 1999 Feb; 50(2):135-42. PubMed ID: 10368035
[TBL] [Abstract][Full Text] [Related]
16. The relative biological effectiveness of the modulated proton beam at TRIUMF.
Nemoto K; Pickles T; Minchinton AI; Lam GK
Radiat Med; 1998; 16(1):43-6. PubMed ID: 9568632
[TBL] [Abstract][Full Text] [Related]
17. Changes in RBE of 14-MeV (d + T) neutrons for V79 cells irradiated in air and in a phantom: is RBE enhanced near the surface?
Schalla S; Herskind C; Höver KH; Lorenz WJ; Hahn EW
Strahlenther Onkol; 1998 Apr; 174(4):204-11. PubMed ID: 9581181
[TBL] [Abstract][Full Text] [Related]
18. Relative biological effectiveness (RBE) values for proton beam therapy.
Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo simulations of therapeutic proton beams for relative biological effectiveness of double-strand break.
Wang CC; Hsiao Y; Lee CC; Chao TC; Wang CC; Tung CJ
Int J Radiat Biol; 2012 Jan; 88(1-2):158-63. PubMed ID: 21823821
[TBL] [Abstract][Full Text] [Related]
20. Relative biological effectiveness measurements using murine lethality and survival of intestinal and hematopoietic stem cells after fermilab neutrons compared to JANUS reactor neutrons and 60Co gamma rays.
Hanson WR; Crouse DA; Fry RJ; Ainsworth EJ
Radiat Res; 1984 Nov; 100(2):290-7. PubMed ID: 6494441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
